S&P 500   3,941.26 (-1.44%)
DOW   33,596.34 (-1.03%)
QQQ   281.69 (-2.07%)
AAPL   142.96 (-2.50%)
MSFT   244.96 (-2.09%)
META   114.12 (-6.79%)
GOOGL   96.99 (-2.50%)
AMZN   88.43 (-2.83%)
TSLA   179.85 (-1.43%)
NVDA   159.89 (-3.74%)
NIO   13.19 (+3.05%)
BABA   91.40 (+0.97%)
AMD   70.41 (-4.36%)
T   19.15 (+2.13%)
MU   53.77 (-0.50%)
CGC   3.61 (-16.44%)
F   13.29 (-0.67%)
GE   85.31 (+0.77%)
DIS   92.50 (-3.58%)
AMC   6.74 (-9.53%)
PYPL   72.25 (-1.86%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
S&P 500   3,941.26 (-1.44%)
DOW   33,596.34 (-1.03%)
QQQ   281.69 (-2.07%)
AAPL   142.96 (-2.50%)
MSFT   244.96 (-2.09%)
META   114.12 (-6.79%)
GOOGL   96.99 (-2.50%)
AMZN   88.43 (-2.83%)
TSLA   179.85 (-1.43%)
NVDA   159.89 (-3.74%)
NIO   13.19 (+3.05%)
BABA   91.40 (+0.97%)
AMD   70.41 (-4.36%)
T   19.15 (+2.13%)
MU   53.77 (-0.50%)
CGC   3.61 (-16.44%)
F   13.29 (-0.67%)
GE   85.31 (+0.77%)
DIS   92.50 (-3.58%)
AMC   6.74 (-9.53%)
PYPL   72.25 (-1.86%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
S&P 500   3,941.26 (-1.44%)
DOW   33,596.34 (-1.03%)
QQQ   281.69 (-2.07%)
AAPL   142.96 (-2.50%)
MSFT   244.96 (-2.09%)
META   114.12 (-6.79%)
GOOGL   96.99 (-2.50%)
AMZN   88.43 (-2.83%)
TSLA   179.85 (-1.43%)
NVDA   159.89 (-3.74%)
NIO   13.19 (+3.05%)
BABA   91.40 (+0.97%)
AMD   70.41 (-4.36%)
T   19.15 (+2.13%)
MU   53.77 (-0.50%)
CGC   3.61 (-16.44%)
F   13.29 (-0.67%)
GE   85.31 (+0.77%)
DIS   92.50 (-3.58%)
AMC   6.74 (-9.53%)
PYPL   72.25 (-1.86%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
S&P 500   3,941.26 (-1.44%)
DOW   33,596.34 (-1.03%)
QQQ   281.69 (-2.07%)
AAPL   142.96 (-2.50%)
MSFT   244.96 (-2.09%)
META   114.12 (-6.79%)
GOOGL   96.99 (-2.50%)
AMZN   88.43 (-2.83%)
TSLA   179.85 (-1.43%)
NVDA   159.89 (-3.74%)
NIO   13.19 (+3.05%)
BABA   91.40 (+0.97%)
AMD   70.41 (-4.36%)
T   19.15 (+2.13%)
MU   53.77 (-0.50%)
CGC   3.61 (-16.44%)
F   13.29 (-0.67%)
GE   85.31 (+0.77%)
DIS   92.50 (-3.58%)
AMC   6.74 (-9.53%)
PYPL   72.25 (-1.86%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
EPA:SAN

Sanofi - SAN Stock Forecast, Price & News

€85.94
+0.17 (+0.20%)
(As of 12/5/2022 12:00 AM ET)
Add
Compare
Today's Range
€85.03
€86.75
50-Day Range
€77.44
€88.19
52-Week Range
€63.09
€92.97
Volume
1.33 million shs
Average Volume
3.05 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
€108.86
SAN stock logo

About Sanofi (EPA:SAN) Stock

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

Receive SAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sanofi and its competitors with MarketBeat's FREE daily newsletter.

SAN Stock News Headlines

UPDATE 1-Provention Bio diabetes drug to cost $13,850/vial
Sanofi (SNY) Stock Moves -0.1%: What You Should Know
See More Headlines
Receive SAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sanofi and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Drug Manufacturers - Major
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
95,442
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
€108.86
High Stock Price Forecast
€124.00
Low Stock Price Forecast
€80.00
Forecasted Upside/Downside
+26.7%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Optionable
Beta
N/A

Key Executives

  • Mr. Paul Hudson (Age 55)
    CEO & Director
    Comp: $5.64M
  • Mr. Jean-Baptiste Chasseloup de Chatillon (Age 57)
    Exec. VP & CFO
  • Mr. Laurent Gilhodes
    Principal Accounting Officer and VP of Corp. Accounting
  • Mr. Bruno Ménard
    Chief Information officer
  • Dr. Josephine Fubara
    Chief Science Officer of Consumer Health Care
  • Eva Schaefer-Jansen
    Head of Investor Relations
  • Mr. Dante Beccaria
    Global Compliance Officer & VP
  • Mr. Roy Papatheodorou (Age 44)
    Exec. VP, Gen. Counsel and Head of Legal, Ethics & Bus. Integrity
  • Mr. Josep Catlla
    Head of Communications
  • Mr. Pierre Chancel (Age 65)
    Sr. VP of Global Diabetes and Sr. VP of Global Marketing













SAN Stock - Frequently Asked Questions

What is Sanofi's stock price forecast for 2023?

0 brokerages have issued 12-month target prices for Sanofi's stock. Their SAN share price forecasts range from €80.00 to €124.00. On average, they anticipate the company's share price to reach €108.86 in the next year. This suggests a possible upside of 26.7% from the stock's current price.
View analysts price targets for SAN
or view top-rated stocks among Wall Street analysts.

How have SAN shares performed in 2022?

Sanofi's stock was trading at €88.58 at the start of the year. Since then, SAN stock has decreased by 3.0% and is now trading at €85.94.
View the best growth stocks for 2022 here
.

What other stocks do shareholders of Sanofi own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sanofi investors own include Skechers U.S.A. (SKX), NVIDIA (NVDA), Sanofi (SNY), Intel (INTC), Salesforce (CRM), Bank of America (BAC), Tronox (TROX), Advanced Micro Devices (AMD) and Tesla (TSLA).

What is Sanofi's stock symbol?

Sanofi trades on the EPA under the ticker symbol "SAN."

What is Sanofi's stock price today?

One share of SAN stock can currently be purchased for approximately €85.94.

How many employees does Sanofi have?

The company employs 95,442 workers across the globe.

How can I contact Sanofi?

Sanofi's mailing address is 54 rue la Boetie, PARIS, 75008, France. The official website for the company is en.sanofi.com. The company can be reached via phone at +33-1-53774000.

This page (EPA:SAN) was last updated on 12/6/2022 by MarketBeat.com Staff